Compound information
- Natural Products
- ZC974591
- Molecular Formula
- C14H20NO7P
- Molecular Weight
- 345.09773861 g/mol
- Structure
-
- IUPAC Name
- ethyl (2S)-2-(benzyloxycarbonylamino)-2-dimethoxyphosphoryl-acetate
- InChI
- InChI=1S/C14H20NO7P/c1-4-21-13(16)12(23(18,19-2)20-3)15-14(17)22-10-11-8-6-5-7-9-11/h5-9,12H,4,10H2,1-3H3,(H,15,17)/t12-/m0/s1
- InChI Key
- UKCIYRLSZNPVJK-LBPRGKRZSA-N
- SMILES
- CCOC(=O)[C@@H](NC(=O)OCc1ccccc1)P(=O)(OC)OC
- Source
- ZINC000035571049
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 23 | Ring Count | 1 |
Heteroatom Count | 9 | Rotatable Bond Count | 8 |
Hydrogen Bond Acceptor Count | 7 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 100.16 Å2 | LogP | 1.278 |
LogS | -2.35 | LogD | 1.247 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.021 | Pgp substrate | 0.001 |
HIA | 0.975 | F20 % | 0.983 |
F30 % | 0.441 | Caco-2 | -4.988 |
MDCK | -4.585 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.034 | PPB | 78.708 |
VD | 0.392 | Fu | 0.968 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.001 | CYP1A2 substrate | 0.658 |
CYP2A6 substrate | 0.524 | CYP2B6 substrate | 0.653 |
CYP2C19 inhibitor | 0.945 | CYP2C19 substrate | 0.923 |
CYP2C8 substrate | 0.734 | CYP2C9 inhibitor | 0.058 |
CYP2C9 substrate | 0.814 | CYP2D6 inhibitor | 0.001 |
CYP2D6 substrate | 0.534 | CYP2E1 substrate | 0.555 |
CYP3A4 inhibitor | 0.008 | CYP3A4 substrate | 0.973 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.828 | CL | 4.802 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.049 | Hepatotoxicity | 0.559 |
Mutagenicity | 0.278 | Rat Oral Acute Toxicity | 0.098 |
FDAMDD | 0.088 | Skin Sensitization | 0.017 |
Carcinogenicity | 0.003 | Eye Corrosion | 0.002 |
Eye Irritation | 0.033 | Respiratory Toxicity | 0.059 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.8 | IGC50 | 2.037 |
LC50FM | 3.721 | LC50DM | 6.79 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.137 | NR-AR-LBD | 0.219 |
NR-AhR | 0.023 | NR-Aromatase | 0.105 |
NR-ER | 0.219 | NR-ER-LBD | 0.453 |
NR-PPAR-gamma | 0.185 | SR-ARE | 0.304 |
SR-ATAD5 | 0.341 | SR-HSE | 0.031 |
SR-MMP | 0.008 | SR-p53 | 0.022 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.